SEARCH

SEARCH BY CITATION

References

  • 1
    Devesa SS, Silverman DT, Young JL Jr et al. Cancer incidence and mortality trends among whites in the United States, 1947–1984. J Natl Cancer Inst 1987; 79: 701770.
  • 2
    Brinton LA, Fraumeni JF Jr. Epidemiology of uterine cervical cancer. J Chronic Dis 1986; 39: 10511065.
  • 3
    Cutler SJ, Young JL Jr. Third national cancer survey: Incidence data. Natl Cancer Inst Monogr 1975; 41: 1454.
  • 4
    Heston JF, Kelly JB, Meigs JW, Flannery JT. Forty-five years of cancer incidence in Connecticut: 1935–79. Natl Cancer Inst Monogr 1986; 70: 1706.
  • 5
    Young JL Jr, Percy CL, Asire AJ. Surveillance, epidemiology, end results: Incidence and mortality data, 1973–77. Natl Cancer Inst Monogr 1981; 57: 11082.
  • 6
    Horm JW, Asire AJ, Young JL Jr, Pollack ES. SEER Program: Cancer Incidence and Mortality in the United States, 1973–81 (DHHS publication no. [NIH] 85–1837). Bethesda, MD: National Institutes of Health, 1984.
  • 7
    Mason TJ, McKay FW, Hoover R, Blot WJ, Fraumeni JF Jr. Atlas of Cancer Mortality for US Counties: 1950–1969 (DHEW publication no. [NIH] 75–780). Washington, DC: US Government Printing Office, 1975.
  • 8
    Pickle LW, Mason TJ, Howard N, Hoover R, Fraumeni JF Jr. Atlas of US Cancer Mortality Rates and Trends Among Whites, 1950–1980 (DHHS publication no. [NIH] 87–2900). Washington, DC: US Government Printing Office, 1987.
  • 9
    Lyon JL, Gardner JW. The rising frequency of hysterectomy: Its effect on uterine cancer rates. Am J Epidemiol 1977; 105: 439443.
  • 10
    Marrett LD. Estimates of the true population at risk of uterine disease and an application to incidence data for cancer of the uterine corpus in Connecticut. Am J Epidemiol 1980; 111: 373378.
  • 11
    Nolan TF, Ory HW, Layde PM, Hughes JM, Greenspan JR. Cumulative prevalence rates and corrected incidence rates of surgical sterilization among women in the United States, 1971–1978. Am J Epidemiol 1982; 116: 776781.
  • 12
    Dicker RC, Scally MJ, Greenspan JR et al. Hysterectomy among women of reproductive age: Trends in the United States, 1970–1978. JAMA 1982; 248: 323327.
  • 13
    Schairer C. Personal communication.
  • 14
    Mitchell H, Medley G, Drake M. Quality control measures for cervical cytology laboratories. Acta Cytol 1988; 32: 288292.
  • 15
    Chu J, White E. Decreasing incidence of invasive cervical cancer in young women. Am J Obstet Gynecol 1987; 157: 11051107.
  • 16
    Peters RK, Chao A, Mack TM, Thomas D, Bernstein L, Henderson BE. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles county. J Natl Cancer Inst 1986; 76: 423428.
  • 17
    Schwartz SM, Weiss NS. Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 1986; 124: 10451047.
  • 18
    Gallagher RP, Elwood JM. Recent trends in recorded incidence and mortality from uterine cancer. Natl Cancer Inst Monogr 1982; 62: 8387.
  • 19
    Carmichael JA, Clarke DH, Moher D, Ohlke ID, Karchmar EJ. Cervical carcinoma in women aged 34 and younger. Am J Obstet Gynecol 1986; 154: 264269.
  • 20
    Gardner MJ, Osmond C. Interpretation of time trends in disease rates in the presence of generation effects. Stat Med 1984; 3: 113130.
  • 21
    Cook GA, Draper GJ. Trends in cervical cancer and carcinoma in situ in Great Britain. Br J Cancer 1984; 50: 367375.
  • 22
    Parkin DM, Nguyen-Dinh X, Day NE. The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynecol 1985; 92: 150157.
  • 23
    Doll R. Invasive cervical cancer and combined oral contraceptives. Br Med J 1985; 290: 1210.
  • 24
    Beral V, Booth M. Predictions of cervical cancer incidence and mortality in England and Wales. Lancet 1986; 1: 495.
  • 25
    Parkin DM, Day NE. Deaths from cervical cancer. Lancet 1986; 1: 797.
  • 26
    Chilvers C, Mant D, Pike MC. Cervical adenocarcinoma and oral contraceptives. Br Med J 1987; 295: 14461447.
  • 27
    Kjellgren O. Mass screening in Sweden for cancer of the uterine cervix: Effect on incidence and mortality. Gynecol Obstet Invest 1986; 22: 5763.
  • 28
    Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: Association with organized screening programmes. Lancet 1987; 1: 12471249.
  • 29
    Eide TJ. Cancer of the uterine cervix in Norway by histologic type, 1970–84. J Natl Cancer Inst 1987; 79: 199205.
  • 30
    Armstrong B, Holman D. Increasing mortality from cancer of the cervix in young Australian women. Med J Aust 1981; 1: 460462.
  • 31
    Bourne RG, Grove WD. Invasive carcinoma of the cervix in Queensland: Change in incidence and mortality, 1959–80. Med J Aust 1983; 1: 156158.
  • 32
    Holman CDJ, Armstrong BK. Cervical cancer mortality trends in Australia: An update. Med J Aust 1987; 146: 410412.
  • 32a
    Biggar RJ, Brinton LA, Rosenthal MD. Trends in the number of sexual partners among American women. JAIDS (in press).
  • 33
    Brinton LA, Schairer C, Haenszel W et al. Cigarette smoking and invasive cervical cancer. JAMA 1986; 255: 32653269.
  • 34
    Winkelstein W Jr Cigarette smoking and cancer of the uterine cervix. Banbury Rep 1986; 23: 329341.
  • 35
    Brinton LA, Tashima KT, Lehman HF et al. Epidemiology of cervical cancer by cell type. Cancer Res 1987; 47: 17061711.
  • 36
    US Department of Health and Human Services. The health consequences of smoking for women: A report of the Surgeon General. Rockville, MD: Office on Smoking and Health, 1980.
  • 37
    National Center for Health Statistics, US Department of Health and Human Services. Health, United States, 1987 (DHHS publication no. [PHS] 88–1232). Hyattsville, MD: National Center for Health Statistics, 1988.
  • 38
    Devesa SS, Silverman DT. Cancer incidence and mortality trends in the United States: 1935–74. J Natl Cancer Inst 1978; 60: 545571.
  • 39
    World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Invasive cervical cancer and combined oral contraceptives. Br Med J 1985; 290: 961965.
  • 40
    Brinton LA, Huggins GR, Lehman HF et al. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer 1986; 38: 339344.
  • 41
    Piper JM, Kennedy DL. Oral contraceptives in the United States: Trends in content and potency. Int J Epidemiol 1987; 16: 215221.
  • 42
    National Center for Health Statistics, US Department of Health and Human Services. Health, United States, 1985 (DHHS publication no. [PHS] 86–1232). Hyattsville, MD: National Center for Health Statistics, 1985.
  • 43
    Chow WH, Greenberg RS, Liff JM. Decline in the incidence of carcinoma in situ of the cervix. Am J Public Health 1986; 76: 13221324.
  • 44
    Moss AJ, Wilder MH. Use of selected medical procedures associated with preventive care, United States: 1973. Vital and Health Statistics, series 10, no. 110 (DHEW publication no. [HRA] 77–1538). Rockville, MD: National Center for Health Statistics, 1977.
  • 45
    Bloom B. Use of selected preventive care procedures, United States: 1982. Vital and Health Statistics, series 10, no. 157 (DHHS publication no. [PHS] 86–1585). Hyattsville, MD: National Center for Health Statistics, 1986.
  • 46
    Centers for Disease Control. Provisional estimates from the National Health Interview Survey Supplement on Cancer Control: United States, January–March 1987. Morbidity Mortality Weekly Rep 1988; 37: 417425.
  • 47
    IARC Working Group on Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: Duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J 1986; 293: 659664.
  • 48
    Parkin DM, Moss SM. An evaluation of screening policies for cervical cancer in England and Wales using a computer simulation model. J Epidemiol Commun Health 1986; 40: 143153.
  • 49
    Eddy DM. The frequency of cervical cancer screening: Comparison of a mathematical model with empirical data. Cancer 1987; 60: 11171122.